Dr. Hönle Reports Q2 Revenue and EBITDA Growth Amid Sector Challenges
Dr. Hönle reported improved second-quarter results with revenue rising to EUR 23.8 million and EBITDA reaching EUR 2.2 million, driven by better product mix and cost discipline. However, the Curing segment continued to underperform due to weak demand in plant engineering and mechanical sectors.
Topics: business unit performance EBITDA improvement financial performance revenue growth